» Articles » PMID: 20058228

Cognitive-nigrostriatal Relationships in De Novo, Drug-naïve Parkinson's Disease Patients: a [I-123]FP-CIT SPECT Study

Overview
Journal Mov Disord
Date 2010 Jan 9
PMID 20058228
Citations 39
Authors
Affiliations
Soon will be listed here.
Abstract

To unveil cognitive-nigrostriatal correlations in Parkinson's disease (PD), 30 de novo, drug-naïve PD patients and 15 patients with essential tremor (Controls, CTR) underwent a neuropsychological (NPS) battery and brain SPECT with [I-123]Ioflupane, as a biomarker of nigrostriatal function. Automatic extraction of uptake at caudate and putamen level was conducted through the BasGan software, also allowing partial volume effect correction. Because of the multicollinearity among neuropsychological tests and among SPECT variables, factor analysis was applied to 16 neuropsychological scores; moreover, the four SPECT variables were merged into a mean SPECT value (mSPECT). Factor analysis identified four NPS factors: a dys-executive (NPS-EX), a visuospatial (NPS-VS), a verbal memory (NPS-VM), and a "mixed" (NPD-MIX) factor. In PD group, there were inverse correlations between UPDRS-III score and both NPS-VS (P < 0.01) and mSPECT (P < 0.05), and a direct correlation between mSPECT and NPS-EX (P < 0.05). Post hoc analysis showed a direct correlation between NPS-EX and caudate uptake in both hemispheres (P < 0.05). Moreover, inverse correlations were found between UPDRS-III and, respectively, putamen uptake in the less affected hemisphere (P < 0.01), and putamen and caudate uptake in the more affected hemisphere (P < 0.05). In CTR, no correlation was found between mSPECT and either NPS or GDS values. Nigro-caudate function affects executive capabilities in PD but not in CTR, which appears to be unrelated to the disease motor severity at its onset. Instead, PD motor severity is related to nigro-putaminal impairment and visuospatial dysfunction. The role of these data as predictive features of cognitive decline and eventually dementia remains to be established in longitudinal studies.

Citing Articles

Radionuclide Imaging of the Neuroanatomical and Neurochemical Substrate of Cognitive Decline in Parkinson's Disease.

Booth S, Ko J Nucl Med Mol Imaging. 2024; 58(4):213-226.

PMID: 38932760 PMC: 11196570. DOI: 10.1007/s13139-024-00842-9.


PINK1 knockout rats show premotor cognitive deficits measured through a complex maze.

Soto I, Nejtek V, Siderovski D, Salvatore M Front Neurosci. 2024; 18:1390215.

PMID: 38817910 PMC: 11137248. DOI: 10.3389/fnins.2024.1390215.


Presynaptic Dopaminergic Imaging Characterizes Patients with REM Sleep Behavior Disorder Due to Synucleinopathy.

Arnaldi D, Mattioli P, Raffa S, Pardini M, Massa F, Iranzo A Ann Neurol. 2024; 95(6):1178-1192.

PMID: 38466158 PMC: 11102309. DOI: 10.1002/ana.26902.


Impact of the Dopamine System on Long-Term Cognitive Impairment in Parkinson Disease: An Exploratory Study.

Weintraub D, Picillo M, Cho H, Caspell-Garcia C, Blauwendraat C, Brown E Mov Disord Clin Pract. 2023; 10(6):943-955.

PMID: 37332638 PMC: 10272925. DOI: 10.1002/mdc3.13751.


Validation of dynamic [F]FE-PE2I PET for estimation of relative regional cerebral blood flow: a comparison with [O]HO PET.

Jakobson Mo S, Axelsson J, Stiernman L, Riklund K EJNMMI Res. 2022; 12(1):72.

PMID: 36394638 PMC: 9672223. DOI: 10.1186/s13550-022-00941-8.